The best performing exchange-traded fund so far this year tracks cannabis stocks.

The top 15 ETFs have all gained at least 26% in 2019.

ETFs tracking Chinese equities made the most frequent appearance, taking six of the top 15 slots.

Many exchange-traded funds have rocketed higher in 2019 alongside a broader recovery in markets, driven bythe Feds pause of its interest-rate hikesas well as the adoption of a more dovish outlook.

In addition,fears of a recession in the US have eased, with market commentators indicating theworst of the slowdown may even have passed in the US and China.

ETFs tracking the surging Chinese stock market took the lions share of the top 15 spots, with six making an appearance.

Meanwhile, an ETF tracing the red-hot cannabis industry led the pack, posting a return of 46%. Top holdings of the ETF include Aurora Cannabis, GW Pharmaceuticals, and Cronos Group, which have soared amid moves towards the legalization of marijuana production and distribution in the US.

Check out the 15 top-performing ETFs of Q1, excluding levered ETFs and those with assets under $100 million from our selection:

The index tracks the performance of companies across the globe, including in the US, that are engaged exclusively in legal activities of cannabis for medical or non-medical purposes.

Companies within ARKG are focused on and are expected to substantially benefit from extending and enhancing the quality of human and other life by incorporating technological and scientific developments and advancements in genomics into their business.

The ETF seeks to track the A-shares of domestic Chinese equities that trade on the Shanghai or Shenzhen stock exchanges, tracking over 300 companies.

The ETF seeks to track the progressive partial inclusion of A shares in the MSCI Emerging Markets Index over time.

The ETF seeks to track the A-shares of domestic Chinese equities that trade on the Shanghai or Shenzhen stock exchanges. The ETF tracks over 200 holdings.

The ETF seeks to track the A-shares of domestic Chinese equities that trade on the Shanghai or Shenzhen stock exchanges. The ETF tracks over 200 holdings.

The ETF is designed to identify companies that are showing momentum among the DWA Technology Technical Leaders Index. The ETF is composed of at least 30 securities from the Nasdaq.

The ETF invests in the stocks of companies operating in the biotechnology and pharmaceutical sectors, with a market capitalization of no less than $200 million and no more than $5 billion.

The ETF seeks to invest in the consumer discretionary sector among the A-shares of domestic Chinese equities that trade on the Shanghai or Shenzen stock exchange.

The ETF seeks to provide exposure to the oil and gas equipment and services segment of the S&P total market index, which comprises the oil & gas drilling sub-industry and the oil & gas equipment & services sub-industry.

The ETF invests in US exchange-listed companies that are headquartered or incorporated in the Peoples Republic of China.

The index seeks to track the investment results of Chinese companies that are not state-owned enterprises, which is defined as government ownership of greater than 20%.

The ETF seeks to provide exposure to the software and services segment of the S&P total market index, which comprises the following sub-industries: Application software, data processing & outsourced services, home entertainment software, IT consulting & other services, and systems software.

The ETF is composed of securities with strong growth characteristics selected from the Russell Midcap Index.

The ETF seeks to provide exposure to the biotechnology segment of the S&P total market index.

SEE ALSO:Billions of dollars are pouring into Saudi Arabia as investing in the kingdom becomes easier than ever. That has Wall Street grappling with a major ethical dilemma. »READ NOW:Huawei, the Chinese tech giant embroiled in controversy, just overtook Apple to become the second largest smartphone maker (AAPL) »SUBSCRIBE NOW:SHARE THIS POSTFACEBOOKTWITTEREMAILCOPY LINKyourMARKET VIEW

These 15 ETFs made you a killing in the first quarter